Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT AND SERVICE SEGMENT LIFELINE CURVE
2.8 MARKET END USER COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTERS ANALYSIS
5 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, INDUSTRY INSIGHTS
6 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING DEMAND FOR TOXICOLOGY TESTING PRODUCTS
7.1.2 RAPIDLY GROWING PHARMACEUTICAL AND MEDICAL DEVICE INDUSTRIES
7.1.3 RISING INVESTMENT IN R&D BY KEY MARKET PLAYERS
7.1.4 TECHNOLOGICAL ADVANCEMENTS TO DEVELOP NEW TOXICOLOGY TESTING METHODS
7.2 RESTRAINTS
7.2.1 HIGH COSTS ASSOCIATED WITH IN-VITRO TOXICOLOGY TESTING AND PRODUCTS
7.2.2 COMPLEXITY OF BIOLOGICAL SYSTEMS
7.2.3 NEED FOR SKILLED PERSONNEL AND INFRASTRUCTURE
7.3 OPPORTUNITIES
7.3.1 GROWING ADOPTION OF QUALITY CHECK PRODUCTS TO PREVENT PRODUCT RECALLS
7.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS FOR MARKET EXPANSION
7.3.3 GROWING DEMAND FOR PERSONALIZED MEDICINE AND PRECISION TOXICOLOGY
7.4 CHALLENGES
7.4.1 ETHICAL AND PUBLIC PERCEPTION
7.4.2 REGULATORY ACCEPTANCE AND ENDORSEMENT OF IN-VITRO TESTING METHODS
8 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE
8.1 OVERVIEW
8.2 CONSUMABLES
8.3 SERVICES
8.3.1 CYTOTOXICITY
8.3.2 GENE TOXICITY
8.3.3 HEPATOTOXICITY
8.3.4 OPHTHALMIC TOXICITY
8.3.5 CARDIOTOXICITY
8.3.6 NEPHROTOXICITY
8.3.7 NEUROTOXICITY
8.3.8 OTHERS
8.4 ASSAYS
8.4.1 CELL-BASED ELISA & WESTERN BLOTS
8.4.2 ENZYME TOXICITY ASSAYS
8.4.3 RECEPTOR-BINDING ASSAYS
8.4.4 BACTERIAL TOXICITY ASSAYS
8.4.5 TISSUE CULTURE ASSAYS
8.4.6 OTHER ASSAYS
8.5 EQUIPMENTS
8.6 SOFTWARE
9 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST
9.1 OVERVIEW
9.2 ADME (ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION) TESTING
9.3 CYTOTOXICITY TESTING
9.4 GENOTOXICITY TESTING
9.5 DERMAL TOXICITY TESTING
9.6 OCULAR TOXICITY TESTING
9.7 ORGAN TOXICITY TESTING
9.8 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING
9.9 PHOTOTOXICITY TESTING
9.1 OTHER TOXICITY ENDPOINTS AND TESTS
10 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY
10.1 OVERVIEW
10.2 CELL CULTURE TECHNOLOGIES
10.3 HIGH-THROUGHPUT TECHNOLOGIES
10.4 MOLECULAR IMAGING
10.5 OMICS TECHNOLOGY
11 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD
11.1 OVERVIEW
11.2 CELLULAR ASSAYS
11.3 BIOCHEMICAL ASSAYS
11.4 EX-VIVO MODELS
11.5 IN SILICO MODELS
12 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY
12.1 OVERVIEW
12.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
12.2.1 CONSUMABLES
12.2.2 SERVICES
12.2.3 ASSAYS
12.2.4 EQUIPMENTS
12.2.5 SOFTWARE
12.3 DIAGNOSTICS
12.3.1 CONSUMABLES
12.3.2 SERVICES
12.3.3 ASSAYS
12.3.4 EQUIPMENTS
12.3.5 SOFTWARE
12.4 FOOD
12.4.1 CONSUMABLES
12.4.2 SERVICE
12.4.3 ASSAYS
12.4.4 EQUIPMENTS
12.4.5 SOFTWARE
12.5 CHEMICALS
12.5.1 CONSUMABLES
12.5.2 SERVICES
12.5.3 ASSAYS
12.5.4 EQUIPMENTS
12.5.5 SOFTWARE
12.6 COSMETICS AND HOUSEHOLD PRODUCTS
12.6.1 CONSUMABLES
12.6.2 SERVICES
12.6.3 ASSAYS
12.6.4 EQUIPMENTS
12.6.5 SOFTWARE
13 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 RETAIL SALES
13.4 OTHERS
14 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY
14.1 NORTH AMERICA
14.1.1 U.S.
14.1.2 CANADA
14.1.3 MEXICO
15 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 THERMO FISHER SCIENTIFIC INC.
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENT
17.2 LABCORP DRUG DEVELOPMENT
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 PRODUCT PORTFOLIO
17.2.4 RECENT DEVELOPMENT
17.3 MERCK KGAA
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENT
17.4 CHARLES RIVER LABORATORIES.
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENT
17.5 LONZA
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENT
17.6 AAT BIOQUEST, INC.
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENTS
17.7 ARAGEN LIFE SCIENCES LTD.
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENT
17.8 BIOIVT
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENT
17.9 BIO-RAD LABORATORIES, INC.
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENT
17.1 CATALENT, INC
17.10.1 COMPANY SNAPSHOT
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENT
17.11 CREATIVE BIOARRAY.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENTS
17.12 CREATIVE BIOLABS.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENTS
17.13 CYPROTEX LIMITED
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 EUROFINS SCIENTIFIC
17.14.1 COMPANY SNAPSHOT
17.14.2 REVENUE ANALYSIS
17.14.3 PRODUCT PORTFOLIO
17.14.4 RECENT DEVELOPMENT
17.15 GENTRONIX
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 IONTOX
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 INSPHERO.
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENT
17.18 INTERTEK GROUP PLC
17.18.1 COMPANY SNAPSHOT
17.18.2 REVENUE ANALYSIS
17.18.3 PRODUCT PORTFOLIO
17.18.4 RECENT DEVELOPMENT
17.19 MB RESEARCH LABORATORIES
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENTS
17.2 PREFERRED CELL SYSTEMS
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENTS
17.21 PROMEGA CORPORATION
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENTS
17.22 QIAGEN
17.22.1 COMPANY SNAPSHOT
17.22.2 REVENUE ANALYSIS
17.22.3 PRODUCT PORTFOLIO
17.22.4 RECENT DEVELOPMENTS
17.23 SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENTS
17.24 SHANGHAI MEDICILON INC.
17.24.1 COMPANY SNAPSHOT
17.24.2 REVENUE ANALYSIS
17.24.3 PRODUCT PORTFOLIO
17.24.4 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 2 NORTH AMERICA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 3 NORTH AMERICA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 4 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 6 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 12 NORTH AMERICA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 14 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 15 NORTH AMERICA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 16 NORTH AMERICA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 17 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 18 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 19 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 20 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 21 NORTH AMERICA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 22 NORTH AMERICA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 27 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 28 U.S. SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 29 U.S. ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 30 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 31 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 32 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 33 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 34 U.S. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 35 U.S. DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 36 U.S. FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 37 U.S. CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 38 U.S. COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 39 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 40 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 41 CANADA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 42 CANADA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 43 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 44 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 45 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 46 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 47 CANADA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 48 CANADA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 49 CANADA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 50 CANADA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 51 CANADA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 52 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 53 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 54 MEXICO SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 55 MEXICO ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 56 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 57 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 58 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 59 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 60 MEXICO PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 61 MEXICO DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 62 MEXICO FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 63 MEXICO CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 64 MEXICO COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 65 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: SEGMENTATION
FIGURE 11 RISING DEMAND FOR TOXICOLOGY TESTING PRODUCTS AND RAPIDLY GROWING PHARMACEUTICAL AND MEDICAL INDUSTRIES ARE EXPECTED TO DRIVE THE GROWTH OF THE NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET FROM 2023 TO 2030
FIGURE 12 THE CONSUMABLES SEGMENT, IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET
FIGURE 14 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE, 2022
FIGURE 15 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE, 2023-2030 (USD MILLION)
FIGURE 16 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE, CAGR (2023-2030)
FIGURE 17 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE, LIFELINE CURVE
FIGURE 18 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY TOXICOLOGY ENDPOINT AND TEST, 2022
FIGURE 19 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY TOXICOLOGY ENDPOINT AND TEST, 2020-2029 (USD MILLION)
FIGURE 20 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY TOXICOLOGY ENDPOINT AND TEST, CAGR (2023-2030)
FIGURE 21 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY TOXICOLOGY ENDPOINT AND TEST, LIFELINE CURVE
FIGURE 22 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY TECHNOLOGY, 2022
FIGURE 23 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION)
FIGURE 24 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY TECHNOLOGY, CAGR (2023-2030)
FIGURE 25 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 26 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY METHOD, 2022
FIGURE 27 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY METHOD, 2023-2030 (USD MILLION)
FIGURE 28 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY METHOD, CAGR (2023-2030)
FIGURE 29 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY METHOD, LIFELINE CURVE
FIGURE 30 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY INDUSTRY, 2022
FIGURE 31 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY INDUSTRY, 2023-2030 (USD MILLION)
FIGURE 32 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY INDUSTRY, CAGR (2023-2030)
FIGURE 33 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY INDUSTRY, LIFELINE CURVE
FIGURE 34 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 35 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 36 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 37 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: SNAPSHOT (2022)
FIGURE 39 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022)
FIGURE 40 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 41 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 42 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE (2023-2030)
FIGURE 43 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: COMPANY SHARE 2022 (%)
